866-997-4948(US-Canada Toll Free)

United States Nonalcoholic Steatohepatitis (NASH) Market Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 109 Pages

Notes:
Sales, means the sales volume of Nonalcoholic Steatohepatitis (NASH)
Revenue, means the sales value of Nonalcoholic Steatohepatitis (NASH)

This report studies sales (consumption) of Nonalcoholic Steatohepatitis (NASH) in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Boehringer Ingelheim?
Cerenis Therapeutics?
Connexios Life Sciences?
Genfit?
Islet Sciences?
Nimbus Therapeutics?
Verva Pharmaceuticals?
Viking Therapeutics?
Astazeneca Plc
Galmed Pharmaceuticals Ltd.
GENFIT SA
Gilead Science
Novo Nordisk
Immuron Ltd
Intercepts Pharmaceuticals
Enzo Biochem, Inc
Tobira Therapeutics, Inc.

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Weight Loss Treatment
Insulin-Sensitizing Agents
Lipid-Lowering Drugs
Antioxidants
Other Agents
Split by applications, this report focuses on sales, market share and growth rate of Nonalcoholic Steatohepatitis (NASH) in each application, can be divided into
Phase I
Phase II
Phase III
Clinical Trials

Table of Contents

United States Nonalcoholic Steatohepatitis (NASH) Market Report 2017
1 Nonalcoholic Steatohepatitis (NASH) Overview
1.1 Product Overview and Scope of Nonalcoholic Steatohepatitis (NASH)
1.2 Classification of Nonalcoholic Steatohepatitis (NASH)
1.2.1 Weight Loss Treatment
1.2.2 Insulin-Sensitizing Agents
1.2.3 Lipid-Lowering Drugs
1.2.4 Antioxidants
1.2.5 Other Agents
1.3 Application of Nonalcoholic Steatohepatitis (NASH)
1.3.1 Phase I
1.3.2 Phase II
1.3.3 Phase III
1.3.4 Clinical Trials
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Nonalcoholic Steatohepatitis (NASH) (2012-2022)
1.4.1 United States Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2012-2022)
1.4.2 United States Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2012-2022)

2 United States Nonalcoholic Steatohepatitis (NASH) Competition by Manufacturers
2.1 United States Nonalcoholic Steatohepatitis (NASH) Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Nonalcoholic Steatohepatitis (NASH) Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Nonalcoholic Steatohepatitis (NASH) Average Price by Manufactures (2015 and 2016)
2.4 Nonalcoholic Steatohepatitis (NASH) Market Competitive Situation and Trends
2.4.1 Nonalcoholic Steatohepatitis (NASH) Market Concentration Rate
2.4.2 Nonalcoholic Steatohepatitis (NASH) Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Nonalcoholic Steatohepatitis (NASH) Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by States (2012-2017)
3.2 United States Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by States (2012-2017)
3.3 United States Nonalcoholic Steatohepatitis (NASH) Price by States (2012-2017)

4 United States Nonalcoholic Steatohepatitis (NASH) Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Type (2012-2017)
4.2 United States Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by Type (2012-2017)
4.3 United States Nonalcoholic Steatohepatitis (NASH) Price by Type (2012-2017)
4.4 United States Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Type (2012-2017)

5 United States Nonalcoholic Steatohepatitis (NASH) Sales (Volume) by Application (2012-2017)
5.1 United States Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Application (2012-2017)
5.2 United States Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Nonalcoholic Steatohepatitis (NASH) Manufacturers Profiles/Analysis
6.1 Boehringer Ingelheim?
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Boehringer Ingelheim? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Cerenis Therapeutics?
6.2.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Cerenis Therapeutics? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Connexios Life Sciences?
6.3.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Connexios Life Sciences? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Genfit?
6.4.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Genfit? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Islet Sciences?
6.5.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Islet Sciences? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Nimbus Therapeutics?
6.6.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Nimbus Therapeutics? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Verva Pharmaceuticals?
6.7.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Verva Pharmaceuticals? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Viking Therapeutics?
6.8.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Viking Therapeutics? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Astazeneca Plc
6.9.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Galmed Pharmaceuticals Ltd.
6.10.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Galmed Pharmaceuticals Ltd. Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 GENFIT SA
6.12 Gilead Science
6.13 Novo Nordisk
6.14 Immuron Ltd
6.15 Intercepts Pharmaceuticals
6.16 Enzo Biochem, Inc
6.17 Tobira Therapeutics, Inc.

7 Nonalcoholic Steatohepatitis (NASH) Manufacturing Cost Analysis
7.1 Nonalcoholic Steatohepatitis (NASH) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nonalcoholic Steatohepatitis (NASH)

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Nonalcoholic Steatohepatitis (NASH) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nonalcoholic Steatohepatitis (NASH) Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Nonalcoholic Steatohepatitis (NASH) Market Forecast (2017-2022)
11.1 United States Nonalcoholic Steatohepatitis (NASH) Sales, Revenue Forecast (2017-2022)
11.2 United States Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Type (2017-2022)
11.3 United States Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Application (2017-2022)
11.4 Nonalcoholic Steatohepatitis (NASH) Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Nonalcoholic Steatohepatitis (NASH)
Table Classification of Nonalcoholic Steatohepatitis (NASH)
Figure United States Sales Market Share of Nonalcoholic Steatohepatitis (NASH) by Type in 2015
Figure Weight Loss Treatment Picture
Figure Insulin-Sensitizing Agents Picture
Figure Lipid-Lowering Drugs Picture
Figure Antioxidants Picture
Figure Other Agents Picture
Table Application of Nonalcoholic Steatohepatitis (NASH)
Figure United States Sales Market Share of Nonalcoholic Steatohepatitis (NASH) by Application in 2015
Figure Phase I Examples
Figure Phase II Examples
Figure Phase III Examples
Figure Clinical Trials Examples
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2012-2022)
Figure United States Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2012-2022)
Table United States Nonalcoholic Steatohepatitis (NASH) Sales of Key Manufacturers (2015 and 2016)
Table United States Nonalcoholic Steatohepatitis (NASH) Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Nonalcoholic Steatohepatitis (NASH) Sales Share by Manufacturers
Figure 2016 Nonalcoholic Steatohepatitis (NASH) Sales Share by Manufacturers
Table United States Nonalcoholic Steatohepatitis (NASH) Revenue by Manufacturers (2015 and 2016)
Table United States Nonalcoholic Steatohepatitis (NASH) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Nonalcoholic Steatohepatitis (NASH) Revenue Share by Manufacturers
Table 2016 United States Nonalcoholic Steatohepatitis (NASH) Revenue Share by Manufacturers
Table United States Market Nonalcoholic Steatohepatitis (NASH) Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Nonalcoholic Steatohepatitis (NASH) Average Price of Key Manufacturers in 2015
Figure Nonalcoholic Steatohepatitis (NASH) Market Share of Top 3 Manufacturers
Figure Nonalcoholic Steatohepatitis (NASH) Market Share of Top 5 Manufacturers
Table United States Nonalcoholic Steatohepatitis (NASH) Sales by States (2012-2017)
Table United States Nonalcoholic Steatohepatitis (NASH) Sales Share by States (2012-2017)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Market Share by States in 2015
Table United States Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by States (2012-2017)
Table United States Nonalcoholic Steatohepatitis (NASH) Revenue Share by States (2012-2017)
Figure Revenue Market Share of Nonalcoholic Steatohepatitis (NASH) by States (2012-2017)
Table United States Nonalcoholic Steatohepatitis (NASH) Price by States (2012-2017)
Table United States Nonalcoholic Steatohepatitis (NASH) Sales by Type (2012-2017)
Table United States Nonalcoholic Steatohepatitis (NASH) Sales Share by Type (2012-2017)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Type in 2015
Table United States Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by Type (2012-2017)
Table United States Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nonalcoholic Steatohepatitis (NASH) by Type (2012-2017)
Table United States Nonalcoholic Steatohepatitis (NASH) Price by Type (2012-2017)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Type (2012-2017)
Table United States Nonalcoholic Steatohepatitis (NASH) Sales by Application (2012-2017)
Table United States Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Application (2012-2017)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Application in 2015
Table United States Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Application (2012-2017)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Application (2012-2017)
Table Boehringer Ingelheim? Basic Information List
Table Boehringer Ingelheim? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim? Nonalcoholic Steatohepatitis (NASH) Sales Market Share (2012-2017)
Table Cerenis Therapeutics? Basic Information List
Table Cerenis Therapeutics? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Cerenis Therapeutics? Nonalcoholic Steatohepatitis (NASH) Sales Market Share (2012-2017)
Table Connexios Life Sciences? Basic Information List
Table Connexios Life Sciences? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Connexios Life Sciences? Nonalcoholic Steatohepatitis (NASH) Sales Market Share (2012-2017)
Table Genfit? Basic Information List
Table Genfit? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Genfit? Nonalcoholic Steatohepatitis (NASH) Sales Market Share (2012-2017)
Table Islet Sciences? Basic Information List
Table Islet Sciences? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Islet Sciences? Nonalcoholic Steatohepatitis (NASH) Sales Market Share (2012-2017)
Table Nimbus Therapeutics? Basic Information List
Table Nimbus Therapeutics? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Nimbus Therapeutics? Nonalcoholic Steatohepatitis (NASH) Sales Market Share (2012-2017)
Table Verva Pharmaceuticals? Basic Information List
Table Verva Pharmaceuticals? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Verva Pharmaceuticals? Nonalcoholic Steatohepatitis (NASH) Sales Market Share (2012-2017)
Table Viking Therapeutics? Basic Information List
Table Viking Therapeutics? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Viking Therapeutics? Nonalcoholic Steatohepatitis (NASH) Sales Market Share (2012-2017)
Table Astazeneca Plc Basic Information List
Table Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Sales Market Share (2012-2017)
Table Galmed Pharmaceuticals Ltd. Basic Information List
Table Galmed Pharmaceuticals Ltd. Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Galmed Pharmaceuticals Ltd. Nonalcoholic Steatohepatitis (NASH) Sales Market Share (2012-2017)
Table GENFIT SA Basic Information List
Table Gilead Science Basic Information List
Table Novo Nordisk Basic Information List
Table Immuron Ltd Basic Information List
Table Intercepts Pharmaceuticals Basic Information List
Table Enzo Biochem, Inc Basic Information List
Table Tobira Therapeutics, Inc. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nonalcoholic Steatohepatitis (NASH)
Figure Manufacturing Process Analysis of Nonalcoholic Steatohepatitis (NASH)
Figure Nonalcoholic Steatohepatitis (NASH) Industrial Chain Analysis
Table Raw Materials Sources of Nonalcoholic Steatohepatitis (NASH) Major Manufacturers in 2015
Table Major Buyers of Nonalcoholic Steatohepatitis (NASH)
Table Distributors/Traders List
Figure United States Nonalcoholic Steatohepatitis (NASH) Production and Growth Rate Forecast (2017-2022)
Figure United States Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate Forecast (2017-2022)
Table United States Nonalcoholic Steatohepatitis (NASH) Production Forecast by Type (2017-2022)
Table United States Nonalcoholic Steatohepatitis (NASH) Consumption Forecast by Application (2017-2022)
Table United States Nonalcoholic Steatohepatitis (NASH) Sales Forecast by States (2017-2022)
Table United States Nonalcoholic Steatohepatitis (NASH) Sales Share Forecast by States (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *